Cargando…

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients

Matrix metalloprotease-9 (MMP-9; 92 kDa type IV collaganase, gelatinase B) is regarded as, important for degradation of the basement membrane and extracellular matrix during cancer invasion and other tissue-remodelling events. In this study we evaluate the prognostic value of MMP-9, by immunoperoxid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scorilas, A, Karameris, A, Arnogiannaki, N, Ardavanis, A, Bassilopoulos, P, Trangas, T, Talieri, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363667/ https://www.ncbi.nlm.nih.gov/pubmed/11384099 http://dx.doi.org/10.1054/bjoc.2001.1810

Ejemplares similares

Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis
por: Scorilas, A, et al.
Publicado: (1999)

mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete
por: Yannopoulos, A, et al.
Publicado: (2005)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer
por: Sato, F, et al.
Publicado: (1999)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
por: Hofmann, U B, et al.
Publicado: (1999)

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma
por: Kaasinen, Mirjami, et al.
Publicado: (2022)

Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
por: Tsukifuji, R, et al.
Publicado: (1999)

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma
por: Kikuchi, R, et al.
Publicado: (2000)

Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer
por: Scorilas, A, et al.
Publicado: (2001)

Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression
por: Inoue, Ryo, et al.
Publicado: (2023)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

Association between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients with Breast Cancer
por: Abdollahi, Alireza, et al.
Publicado: (2019)

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation
por: Paju, A, et al.
Publicado: (2001)

The PRMT1 gene expression pattern in colon cancer
por: Mathioudaki, K, et al.
Publicado: (2008)

Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer
por: Vazquez-Ortiz, Guelaguetza, et al.
Publicado: (2005)

The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
por: Rooprai, H K, et al.
Publicado: (2000)

Matrix Metalloproteinase-2 Activated by Ultraviolet-B Degrades Human Ciliary Zonules In Vitro
por: Shiroto, Yuki, et al.
Publicado: (2021)

A Case of Atrophic Dermatofibroma Overexpressing Matrix Metalloproteinase-1
por: Yano-Takamori, Atsuko, et al.
Publicado: (2019)

Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer
por: Yang, Bo, et al.
Publicado: (2014)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during maturation
por: Leśniak-Walentyn, Agnieszka, et al.
Publicado: (2015)

Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
por: Varani, J, et al.
Publicado: (2000)

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
por: Shou, Y, et al.
Publicado: (2001)

Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases
por: Harvey, P, et al.
Publicado: (2000)

Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes
por: Baumann, P, et al.
Publicado: (2000)

Maintenance of the Extracellular Matrix in Rat Anterior Pituitary Gland: Identification of Cells Expressing Tissue Inhibitors of Metalloproteinases
por: Azuma, Morio, et al.
Publicado: (2015)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
por: Forsyth, P A, et al.
Publicado: (1999)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

Role of Matrix Metalloproteinase 9 in Predicting Lymph Node Metastases in Oral Squamous Cell Carcinoma
por: Chakraborty, Satadruti, et al.
Publicado: (2023)

Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline: Implications for nerve regeneration
por: Ali, Sumia, et al.
Publicado: (2014)

Matrix metalloproteinase 9 level as an indicator for restenosis following cervical and intracranial angioplasty and stenting
por: Liu, Jun-peng, et al.
Publicado: (2015)

Matrix Metalloproteinase-2 Degrades Fibrillin-1 and Fibrillin-2 of Oxytalan Fibers in the Human Eye and Periodontal Ligaments In Vitro
por: Kawagoe, Megumi, et al.
Publicado: (2013)

Correction: Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer
por: Vàzquez-Ortiz, Guelaguetza, et al.
Publicado: (2005)

Expression of high p53 levels in colorectal cancer: a favourable prognostic factor
por: Adrover, E, et al.
Publicado: (1999)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
por: Kaminari, Archontia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_19116ki3b4c6gkt7l01j8op6up